NDC 50102-100-10 - LYZA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50102-100
- Requested NDC
- 50102-100-10
- Package NDCs from labels
- 50102-100-00, 50102-100-01, 50102-100-48, 50102-100-10, 50102-100-03
- Manufacturer
- Afaxys Pharma LLC | Mylan Laboratories Limited
- Effective date
- 2021-01-25
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LYZA - Afaxys Pharma LLC | Mylan Laboratories Limited | Afaxys Pharma LLC | Mylan Laboratories Limited | 2021-01-25 | HUMAN PRESCRIPTION DRUG LABEL |
| Lyza® Norethindrone Tablets USP, 0.35 mg | RPK Pharmaceuticals, Inc. | 2020-12-15 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50102-100-03 | 2023-01-30 | C162847 | 48780-1 | f386c649-a411-0266-e053-dadaa90a7c1a | Lyza® Norethindrone Tablets USP, 0.35 mg |
| 50102-100-48 | 2023-01-30 | C162847 | 48780-1 | f386c649-a411-0266-e053-dadaa90a7c1a | Lyza® Norethindrone Tablets USP, 0.35 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50102-100-00 | LYZA | 28 in 1 BLISTER PACK | TABLET | 28 | 13 | |
| 50102-100-01 | LYZA | 1 in 1 PACKAGE | TABLET | 1 | 13 | |
| 50102-100-03 | LYZA | 03 in 1 CARTON | TABLET | 03 | 13 | |
| 50102-100-10 | LYZA | 1 in 1 PACKAGE | TABLET | 1 | 13 | |
| 50102-100-48 | LYZA | 48 in 1 CASE | TABLET | 48 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50102-100-01 | EA - Each | 50102-100 | 2e83f27d-1c30-46f3-84cd-876b7fde59f0 | 1 | 2013-08-02 |
| 50102-100-03 | EA - Each | 50102-100 | bc553cd9-9974-481c-9c5d-aab9d7e94911 | 1 | 2017-04-05 |
| 50102-100-10 | EA - Each | 50102-100 | a6286c6e-7dfb-4afa-a076-3e55e224ae8f | 1 | 2017-08-11 |
| 50102-100-48 | EA - Each | 50102-100 | b2f9741e-ee53-47bc-8aad-bd39ed58901e | 1 | 2013-08-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | FZ989GH94E |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | FZ989GH94E |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| FreshKote Preservative Free Lubricant Eye Drops | POVIDONE, POLYVINYL ALCOHOL | Eyevance Pharmaceuticals | f51c50c3-43ae-4169-9d2b-22b239461dd1 | 2026-04-08 | Warnings | FZ989GH94E |
| Leader Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Cardinal Health | 5c5d6c13-9b51-48f0-8627-b60b0f707fd3 | 2026-03-12 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Sportpharm LLC | 8d58dcbb-72a0-41f0-9eeb-613072a6d7ae | 2026-02-06 | Warnings | FZ989GH94E |
| MINIDROPS | LUBRICANT EYE DROPS | Optics Laboratory, Inc | c13c5f91-50df-471c-a7c9-1747a2ac1250 | 2026-02-03 | Warnings | FZ989GH94E |
| Norethindrone | NORETHINDRONE | Glenmark Pharmaceuticals Inc., USA | 0d2f8fea-3675-40d2-afd9-9fcb148dbd4b | 2026-01-31 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| HEATHER | NORETHINDRONE | Glenmark Pharmaceuticals Inc., USA | 35b5ddb5-1729-4588-b2a2-ead56d78b6f9 | 2026-01-23 | Warnings, Adverse reactions | 748961 198042 T18F433X4S |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.